Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma

Oncogene

Volumn 31, Issue 36, 2012, Pages 4034-4044

  Rusiniak, M E ^a   Kunnev, D ^a   Freeland, A ^a   Cady, G K ^a   Pruitt, S C ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

DNA replication; dormant origins; licensing factor; lymphoblastic lymphoma; Mcm2

Indexed keywords

MINICHROMOSOME MAINTENANCE PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA REPLICATION; GENE DELETION; GENE IDENTIFICATION; GENETIC DAMAGE; HUMAN; LYMPHOBLASTOMA; MBD 3 GENE; MOUSE; NONHUMAN; NOTCH 1 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PTEN GENE; SETD 1B GENE; TCFE 2A GENE; THYMUS LYMPHOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CHROMOSOME BREAKPOINTS; CHROMOSOMES, MAMMALIAN; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENES, NEOPLASM; HUMANS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; THYMUS NEOPLASMS;

MUS;

EID: 84866128502     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.566     Document Type: Article

References (38)

1. Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN. (2003). Translocation and gross deletion breakpoints in human inherited disease and cancer I: nucleotide composition and recombination-associated motifs. Hum Mutat 22: 229.
2. Aftab S, Semenec L, Chu JS, Chen N. (2008). Identification and characterization of novel human tissue-specific RFX transcription factors. BMC Evol Biol 8: 226.
3. Bai T, Seebald JL, Kim KE, Ding HM, Szeto DP, Chang HC. (2010). Disruption of zebrafish cyclin G-associated kinase (GAK) function impairs the expression of Notch-dependent genes during neurogenesis and causes defects in neuronal development. BMC Dev Biol 10: 7.
4. Blow JJ, Dutta A. (2005). Preventing re-replication of chromosomal DNA. Nat Rev 6: 476-486.
5. Blow JJ, Ge XQ, Jackson DA. (2011). How dormant origins promote complete genome replication. Trends Biochem Sci 36: 405-414.
6. Brackertz M, Boeke J, Zhang R, Renkawitz R. (2002). Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3. J Biol Chem 277: 40958-40966.
7. Buckler JL, Liu X, Turka LA. (2008). Regulation of T-cell responses by PTEN. Immunol Rev 224: 239-248.
8. Chuang CH, Wallace MD, Abratte C, Southard T, Schimenti JC. (2010). Incremental genetic perturbations to MCM2-7 expression and subcellular distribution reveal exquisite sensitivity of mice to DNA replication stress. PLoS Genet 6: e1001110.
9. Collins-Underwood JR, Mullighan CG. (2010). Genomic profiling of high-risk acute lymphoblastic leukemia. Leukemia 24: 1676-1685.
10. De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V et al. (2010). The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med 16: 1321-1327.
11. Ge XQ, Blow JJ. (2010). Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories. J Cell Biol 191: 1285-1297.
12. Ge XQ, Jackson DA, Blow J. (2007). Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev 21: 3331-3341.
13. Hess JL. (2004). Mechanisms of transformation by MLL. Crit Rev Eukaryot Gene Exp 14: 235-254.
14. Ibarra A, Schwob E, Mendez J. (2008). Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc Natl Acad Sci USA 105: 8956-8961.
15. Jeannet R, Mastio J, Macias-Garcia A, Oravecz A, Ashworth T, Geimer Le Lay AS et al. (2010). Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL. Blood 116: 5443-5454.
16. Katzav S. (2009). Vav1: a hematopoietic signal transduction molecule involved in human malignancies. Int J Biochem Cell Biol 41: 1245-1248.
17. Kim J, Guermah M, McGinty RK, Lee JS, Tang Z, Milne TA et al. (2009). RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 137: 459-471.
18. Kuiper RP, Schoenmakers EF, van Reijmersdal SV, Hehir-Kwa JY, van Kessel AG, van Leeuwen FN et al. (2007). High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 21: 1258-1266.
19. Kunnev D, Rusiniak ME, Kudla A, Freeland A, Cady GK, Pruitt SC. (2010). DNA damage response and tumorigenesis in Mcm2-deficient mice. Oncogene 29: 3630-3638.
20. LeBrun DP. (2003). E2A basic helix-loop-helix transcription factors in human leukemia. Front Biosci 8: s206-s222.
21. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. (2010). DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363: 2424-2433.
22. Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A et al. (2007). Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 447: 966-971.
23. Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J et al. (2009). New insights to the MLL recombinome of acute leukemias. Leukemia 23: 1490-1499.
24. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. (2007). Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764.
25. Nishiyama A, Xin L, Sharov AA, Thomas M, Mowrer G, Meyers E et al. (2009). Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell 5: 420-433.
26. Orr SJ, Gaymes T, Ladon D, Chronis C, Czepulkowski B, Wang R. (2010). Reducing MCM levels in human primary T cells during the G(0)-4G(1) transition causes genomic instability during the first cell cycle. Oncogene 29: 3803-3814.
27. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. (2007). Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13: 1203-1210.
28. Pruitt SC, Bailey KJ, Freeland A. (2007). Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer. Stem Cells 25: 3121-3132.
29. Ramirez J, Hagman J. (2009). The Mi-2/NuRD complex: a critical epigenetic regulator of hematopoietic development, differentiation and cancer. Epigenetics 4: 532-536.
30. Rebollo A, Schmitt C. (2003). Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol Cell Biol 81: 171-175.
31. Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A et al. (2009). High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood 114: 1053-1062.
32. Santos J, Cerveira N, Correia C, Lisboa S, Pinheiro M, Torres L et al. (2010). Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25). Cancer Genet Cytogenet 197: 60-64.
33. Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, Munroe RJ et al. (2007). A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat Genet 39: 93-98.
34. Tefferi A. (2010). Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24: 1128-1138.
35. Weng AP, Ferrando AA, Lee W, Morris 4th JP, Silverman LB, Sanchez-Irizarry C et al. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271.
36. Williams RT, Sherr CJ. (2008). The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias. Cold Spring Harb Symp Quant Biol 73: 461-467.
37. Yang Q, Kardava L, St Leger A, Martincic K, Varnum-Finney B, Bernstein ID et al. (2008). E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors. J Immunol 181: 5885-5894.
38. Zani VJ, Asou N, Jadayel D, Heward JM, Shipley J, Nacheva E et al. (1996). Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood 87: 3124-3134.